Physician profile
Aashish Gupta
NPI 1073777132
$17,583.42
in general payments reported to CMS, 2019-2025
36 companies · $2,774 in 2025
The $2,774 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,058 · 2020: $1,328 · 2021: $3,195 · 2022: $2,383 · 2023: $2,266 · 2024: $4,579 · 2025: $2,774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,493 · Travel and Lodging: $4,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,493.39 |
| Travel and Lodging | $4,125.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $7,845.47 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Evoque |
| Abbott Laboratories | $2,360.19 | 2020-2025 | Triclip, Esprit, Mitraclip |
| Boston Scientific Corporation | $1,558.55 | 2019-2025 | Avvigo Guidance System, Watchman, Watchman Flx |
| Janssen Pharmaceuticals, INC | $940.80 | 2019-2024 | Xarelto |
| Abiomed | $656.74 | 2019-2025 | |
| Medtronic, INC. | $521.93 | 2021-2025 | Symplicity G3, Linq II, Corevalve Evolut R |
| Pfizer INC. | $519.59 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $415.50 | 2019-2025 | Farxiga, Wainua |
| Inari Medical, INC. | $376.01 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $354.86 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $232.02 | 2020-2025 | Camzyos |
| Recor Medical INC | $189.67 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Novartis Pharmaceuticals Corporation | $167.18 | 2021-2024 | |
| Lantheus Medical Imaging, INC. | $148.44 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $142.06 | 2019-2024 | Lifevest |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $140.24 | 2020 | |
| Atricure, INC. | $136.74 | 2023-2025 | Synergy Ablation System |
| Amgen INC. | $124.55 | 2021-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $115.49 | 2020-2025 | Nexletol |
| Penumbra, INC. | $85.71 | 2022 | |
| Astellas Pharma US INC | $83.76 | 2021 | |
| Novo Nordisk INC | $68.06 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Irhythm Technologies, INC. | $67.32 | 2024 | Zio Monitor, Zio Xt Patch |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.08 | 2023-2025 | Jardiance |
| Cvrx, INC. | $43.48 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $37.32 | 2023-2024 | Inpefa |
| Baxter Healthcare | $34.54 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Imperative Care, INC | $25.99 | 2025 | Symphony Catheter |
| Lilly USA, LLC | $21.92 | 2024 | Zepbound, Mounjaro |
| Canon Medical Systems USA, INC. | $20.84 | 2025 | Interventional Angiography System |
| Merck Sharp & Dohme LLC | $17.34 | 2025 | Verquvo |
| Cook Medical LLC | $14.87 | 2020 | |
| Philips North America LLC | $14.74 | 2025 | Labosys |
| Chiesi USA, INC. | $13.88 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.80 | 2021 | |
| Acutus Medical, INC. | $8.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aashish Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.